DECN Expands Talks Involving Its GenUltimate TBG System, Balances Potential and Competing Outcomes with Recent Intro to 2nd Interested Party
Company Receives 3rd Communique from FDA for Clearance of its GenChoice Test Strip, and at the Request of Agent Paragon,...